EMEA (Europe, Middle East and Africa) Antibody Drug Conjugate Market Report 2017

October 2017 | 118 pages | ID: E70A9F2C979PEN
QYResearch

Abstracts

In this report, the EMEA Antibody Drug Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Antibody Drug Conjugate for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antibody Drug Conjugate market competition by top manufacturers/players, with Antibody Drug Conjugate sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Seattle Genetics/Takeda
• Roche
• ImmunoGen
• Immunomedics
• Pfizer
• Celldex Therapeutics
• Millennium Pharmaceuticals
• Bayer HealthCare
• Mersana Therapeutics
• Heidelberg Pharma
• Oxford BioTherapeutics
• Takeda Pharmaceutical Company Limited

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Adcetris
• Kadcyl
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Antibody Drug Conjugate for each application, including

• Hospital
• Pharmaceutical Company
• Research Institutions

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Antibody Drug Conjugate Market Report 2017

1 ANTIBODY DRUG CONJUGATE OVERVIEW

1.1 Product Overview and Scope of Antibody Drug Conjugate
1.2 Classification of Antibody Drug Conjugate
  1.2.1 EMEA Antibody Drug Conjugate Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Antibody Drug Conjugate Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Adcetris
  1.2.4 Kadcyl
  1.2.5 Other
1.3 EMEA Antibody Drug Conjugate Market by Application/End Users
  1.3.1 EMEA Antibody Drug Conjugate Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Pharmaceutical Company
  1.3.4 Research Institutions
1.4 EMEA Antibody Drug Conjugate Market by Region
  1.4.1 EMEA Antibody Drug Conjugate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antibody Drug Conjugate (2012-2022)
  1.5.1 EMEA Antibody Drug Conjugate Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Antibody Drug Conjugate Revenue and Growth Rate (2012-2022)

2 EMEA ANTIBODY DRUG CONJUGATE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Antibody Drug Conjugate Market Competition by Players/Manufacturers
  2.1.1 EMEA Antibody Drug Conjugate Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Antibody Drug Conjugate Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Antibody Drug Conjugate Sale Price by Players (2012-2017)
2.2 EMEA Antibody Drug Conjugate (Volume and Value) by Type/Product Category
  2.2.1 EMEA Antibody Drug Conjugate Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Antibody Drug Conjugate Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Antibody Drug Conjugate Sale Price by Type (2012-2017)
2.3 EMEA Antibody Drug Conjugate (Volume) by Application
2.4 EMEA Antibody Drug Conjugate (Volume and Value) by Region
  2.4.1 EMEA Antibody Drug Conjugate Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Antibody Drug Conjugate Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Antibody Drug Conjugate Sales Price by Region (2012-2017)

3 EUROPE ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Antibody Drug Conjugate Sales and Value (2012-2017)
  3.1.1 Europe Antibody Drug Conjugate Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Antibody Drug Conjugate Revenue and Growth Rate (2012-2017)
3.2 Europe Antibody Drug Conjugate Sales and Market Share by Type
3.3 Europe Antibody Drug Conjugate Sales and Market Share by Application
3.4 Europe Antibody Drug Conjugate Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Antibody Drug Conjugate Sales Volume by Countries (2012-2017)
  3.4.2 Europe Antibody Drug Conjugate Revenue by Countries (2012-2017)
  3.4.3 Germany Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  3.4.4 France Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  3.4.5 UK Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  3.4.6 Russia Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  3.4.7 Italy Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Antibody Drug Conjugate Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Antibody Drug Conjugate Sales and Value (2012-2017)
  4.1.1 Middle East Antibody Drug Conjugate Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Antibody Drug Conjugate Revenue and Growth Rate (2012-2017)
4.2 Middle East Antibody Drug Conjugate Sales and Market Share by Type
4.3 Middle East Antibody Drug Conjugate Sales and Market Share by Application
4.4 Middle East Antibody Drug Conjugate Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Antibody Drug Conjugate Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Antibody Drug Conjugate Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  4.4.4 Israel Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  4.4.5 UAE Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  4.4.6 Iran Antibody Drug Conjugate Sales and Growth Rate (2012-2017)

5 AFRICA ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Antibody Drug Conjugate Sales and Value (2012-2017)
  5.1.1 Africa Antibody Drug Conjugate Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Antibody Drug Conjugate Revenue and Growth Rate (2012-2017)
5.2 Africa Antibody Drug Conjugate Sales and Market Share by Type
5.3 Africa Antibody Drug Conjugate Sales and Market Share by Application
5.4 Africa Antibody Drug Conjugate Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Antibody Drug Conjugate Sales Volume by Countries (2012-2017)
  5.4.2 Africa Antibody Drug Conjugate Revenue by Countries (2012-2017)
  5.4.3 South Africa Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Antibody Drug Conjugate Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Antibody Drug Conjugate Sales and Growth Rate (2012-2017)

6 EMEA ANTIBODY DRUG CONJUGATE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Seattle Genetics/Takeda
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 ImmunoGen
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Immunomedics
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celldex Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Millennium Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer HealthCare
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Mersana Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Heidelberg Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Antibody Drug Conjugate Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Oxford BioTherapeutics
6.12 Takeda Pharmaceutical Company Limited

7 ANTIBODY DRUG CONJUGATE MANUFACTURING COST ANALYSIS

7.1 Antibody Drug Conjugate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibody Drug Conjugate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibody Drug Conjugate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTIBODY DRUG CONJUGATE MARKET FORECAST (2017-2022)

11.1 EMEA Antibody Drug Conjugate Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Antibody Drug Conjugate Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Antibody Drug Conjugate Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Antibody Drug Conjugate Price and Trend Forecast (2017-2022)
11.2 EMEA Antibody Drug Conjugate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antibody Drug Conjugate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antibody Drug Conjugate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antibody Drug Conjugate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antibody Drug Conjugate Sales Forecast by Type (2017-2022)
11.7 EMEA Antibody Drug Conjugate Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antibody Drug Conjugate
Figure EMEA Antibody Drug Conjugate Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Antibody Drug Conjugate Sales Volume Market Share by Type (Product Category) in 2016
Figure Adcetris Product Picture
Figure Kadcyl Product Picture
Figure Other Product Picture
Figure EMEA Antibody Drug Conjugate Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Antibody Drug Conjugate by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmaceutical Company Examples
Table Key Downstream Customer in Pharmaceutical Company
Figure Research Institutions Examples
Table Key Downstream Customer in Research Institutions
Figure EMEA Antibody Drug Conjugate Market Size (Million USD) by Region (2012-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antibody Drug Conjugate Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antibody Drug Conjugate Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antibody Drug Conjugate Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antibody Drug Conjugate Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Players (2012-2017)
Figure 2016 Antibody Drug Conjugate Sales Share by Players
Figure 2017 Antibody Drug Conjugate Sales Share by Players
Figure EMEA Antibody Drug Conjugate Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue (Million USD) by Players (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue Share by Players (2012-2017)
Table 2016 EMEA Antibody Drug Conjugate Revenue Share by Players
Table 2017 EMEA Antibody Drug Conjugate Revenue Share by Players
Table EMEA Antibody Drug Conjugate Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Antibody Drug Conjugate Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugate by Type (2012-2017)
Figure EMEA Antibody Drug Conjugate Sales Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugate by Type in 2016
Table EMEA Antibody Drug Conjugate Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugate by Application (2012-2017)
Figure EMEA Antibody Drug Conjugate Sales Market Share by Application in 2016
Table EMEA Antibody Drug Conjugate Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugate by Region (2012-2017)
Figure EMEA Antibody Drug Conjugate Sales Market Share in 2016
Table EMEA Antibody Drug Conjugate Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugate by Region (2012-2017)
Figure EMEA Antibody Drug Conjugate Revenue Market Share Regions in 2016
Table EMEA Antibody Drug Conjugate Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Antibody Drug Conjugate Revenue and Growth Rate (2012-2017)
Table Europe Antibody Drug Conjugate Sales (K Units) by Type (2012-2017)
Table Europe Antibody Drug Conjugate Market Share by Type (2012-2017)
Figure Europe Antibody Drug Conjugate Market Share by Type in 2016
Table Europe Antibody Drug Conjugate Sales (K Units) by Application (2012-2017)
Table Europe Antibody Drug Conjugate Market Share by Application (2012-2017)
Figure Europe Antibody Drug Conjugate Market Share by Application in 2016
Table Europe Antibody Drug Conjugate Sales (K Units) by Countries (2012-2017)
Table Europe Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Sales Market Share by Countries in 2016
Table Europe Antibody Drug Conjugate Revenue (Million USD) by Countries (2012-2017)
Table Europe Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Revenue Market Share by Countries in 2016
Figure Germany Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure France Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure UK Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antibody Drug Conjugate Sales (K Units) by Type (2012-2017)
Table Middle East Antibody Drug Conjugate Market Share by Type (2012-2017)
Figure Middle East Antibody Drug Conjugate Market Share by Type (2012-2017)
Table Middle East Antibody Drug Conjugate Sales (K Units) by Applications (2012-2017)
Table Middle East Antibody Drug Conjugate Market Share by Applications (2012-2017)
Figure Middle East Antibody Drug Conjugate Sales Market Share by Application in 2016
Table Middle East Antibody Drug Conjugate Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Antibody Drug Conjugate Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugate Sales Volume Market Share by Countries in 2016
Table Middle East Antibody Drug Conjugate Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugate Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antibody Drug Conjugate Sales (K Units) by Type (2012-2017)
Table Africa Antibody Drug Conjugate Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Type in 2016
Table Africa Antibody Drug Conjugate Sales (K Units) by Application (2012-2017)
Table Africa Antibody Drug Conjugate Sales Market Share by Application (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Application (2012-2017)
Table Africa Antibody Drug Conjugate Sales Volume (K Units) by Countries (2012-2017)
Table Africa Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Countries in 2016
Table Africa Antibody Drug Conjugate Revenue (Million USD) by Countries (2012-2017)
Table Africa Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Revenue Market Share by Countries in 2016
Figure South Africa Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Table Seattle Genetics/Takeda Antibody Drug Conjugate Basic Information List
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Roche Antibody Drug Conjugate Basic Information List
Table Roche Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Roche Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table ImmunoGen Antibody Drug Conjugate Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Immunomedics Antibody Drug Conjugate Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Pfizer Antibody Drug Conjugate Basic Information List
Table Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Pfizer Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Celldex Therapeutics Antibody Drug Conjugate Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Millennium Pharmaceuticals Antibody Drug Conjugate Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Bayer HealthCare Antibody Drug Conjugate Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Mersana Therapeutics Antibody Drug Conjugate Basic Information List
Table Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Heidelberg Pharma Antibody Drug Conjugate Basic Information List
Table Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Oxford BioTherapeutics Antibody Drug Conjugate Basic Information List
Table Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2016
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure EMEA Antibody Drug Conjugate Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drug Conjugate Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drug Conjugate Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Antibody Drug Conjugate Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Antibody Drug Conjugate Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antibody Drug Conjugate Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antibody Drug Conjugate Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antibody Drug Conjugate Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Antibody Drug Conjugate Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antibody Drug Conjugate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antibody Drug Conjugate Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drug Conjugate Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drug Conjugate Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drug Conjugate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drug Conjugate Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drug Conjugate Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Antibody Drug Conjugate Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drug Conjugate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antibody Drug Conjugate Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antibody Drug Conjugate Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Antibody Drug Conjugate Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antibody Drug Conjugate Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Antibody Drug Conjugate Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources